 |
23 Diseases |  |
1 Trial |
|
1 Trial |  |
90 News |  |
| «12 |
- |||||||||| LMTX (hydromethylthionine) / TauRx
New P3 trial: Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Sep 22, 2014
P3, N=1400, Enrolling by invitation, Sponsor: TauRx Therapeutics Ltd
- ||||| LMTX (hydromethylthionine) / TauRx
Trial initiation date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease (clinicaltrials.gov) - Sep 5, 2014
P3, N=700, Ongoing, Sponsor: TauRx Therapeutics Ltd
Initiation date: Nov 2012 --> Apr 2013
- ||||| LMTX (hydromethylthionine) / TauRx
Enrollment closed: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Aug 28, 2014
P3, N=833, Active, not recruiting, Sponsor: TauRx Therapeutics Ltd
Initiation date: Nov 2012 --> Apr 2013 Recruiting --> Active, not recruiting
- |||| LMTX (hydromethylthionine) / TauRx
Trial primary completion date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Aug 6, 2014
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
Recruiting --> Active, not recruiting Trial primary completion date: Jul 2015 --> Dec 2015
- |||| LMTX (hydromethylthionine) / TauRx
Trial primary completion date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 27, 2014
P3, N=833, Recruiting, Sponsor: TauRx Therapeutics Ltd
Trial primary completion date: Jul 2015 --> Dec 2015 Trial primary completion date: Jul 2015 --> Sep 2015
- ||| LMTX (hydromethylthionine) / TauRx
Trial completion date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 27, 2014
P3, N=833, Recruiting, Sponsor: TauRx Therapeutics Ltd
Trial primary completion date: Jul 2015 --> Sep 2015 Trial completion date: Aug 2015 --> Oct 2015
- ||||| LMTX (hydromethylthionine) / TauRx
Trial initiation date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Oct 8, 2013
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
Trial completion date: Aug 2015 --> Oct 2015 Initiation date: Feb 2013 --> Aug 2013
- ||||| LMTX (hydromethylthionine) / TauRx
Enrollment change: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease (clinicaltrials.gov) - Oct 8, 2013
P3, N=700, Recruiting, Sponsor: TauRx Therapeutics Ltd
Initiation date: Feb 2013 --> Aug 2013 N=500 --> 700
- LMTX (hydromethylthionine) / TauRx
Trial termination: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 17, 2013
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
N=500 --> 700 Recruiting --> Terminated; This study has been terminated for administrative reasons only.
- LMTX (hydromethylthionine) / TauRx
Enrollment change: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Apr 17, 2013
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
Recruiting --> Terminated; This study has been terminated for administrative reasons only. N=60 --> 9
- |||||| LMTX (hydromethylthionine) / TauRx
Enrollment open: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Mar 26, 2013
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
N=60 --> 9 Not yet recruiting --> Recruiting
- |||||| LMTX (hydromethylthionine) / TauRx
Enrollment open: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Jan 10, 2013
P3, N=833, Recruiting, Sponsor: TauRx Therapeutics Ltd
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||| LMTX (hydromethylthionine) / TauRx
Enrollment open: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease (clinicaltrials.gov) - Dec 9, 2012
P3, N=700, Recruiting, Sponsor: TauRx Therapeutics Ltd
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| LMTX (hydromethylthionine) / TauRx
New P3 trial: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Sep 19, 2012
P3, N=833, Recruiting, Sponsor: TauRx Therapeutics Ltd
- |||||||||| LMTX (hydromethylthionine) / TauRx
New P3 trial: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease (clinicaltrials.gov) - Sep 19, 2012
P3, N=700, Recruiting, Sponsor: TauRx Therapeutics Ltd
- LMTX (hydromethylthionine) / TauRx
New P2 trial: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease (clinicaltrials.gov) - Jun 20, 2012
P2, N=9, Terminated, Sponsor: TauRx Therapeutics Ltd
- |||||||||| LMTX (hydromethylthionine) / TauRx
New P3 trial: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Jun 20, 2012
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd